To extend these findings to human disease, immunohistochemistry revealed significantly lower BCL2 protein levels in the medial layer of AAA tissues compared with non-AAA aortas, and an immuno-RNA fluorescence in situ hybridization assay further revealed decreased MYOCD mRNA levels in AAA tissues (Supplementary Fig. 9). The gene discussed is BCL2; the disease is triple-A syndrome.